If approved for wide release, the pill, orforglipron, could shake up the booming GLP-1 market by offering an option that's easier to make and store than the injections that are currently available.

Nearly half of generic active pharmaceutical ingredients consumed in the U.S. originate there.

It's Thursday morning, 11:50 a.m. ET -- and Eli Lilly (NYSE: LLY) stock is off to the races! This morning, the ...

The economic showdown between the United States and China is having a massive impact on the American stock market — but Chinese manufacturers and e-commerce giants like Shein and Temu are also facing ...

Headache, sinus pressure, dark circles under the eyes, increased nasal mucus, fatigue, sore throat from post nasal sinus ...

Pfizer said it will stop developing the drug, called danuglipron, as a result Other alternatives to injectable obesity drugs are in development TUESDAY, April 15, 2025 (HealthDay News) — Pfizer has ...

U.S. stocks moved firmly higher in early Monday trading, powered by gains for megacap tech stocks, following President Donald Trump's move to exempt some computers, smartphone and electronics ...

Artillery fire echoed from nearby Gaza as Shye Klein-Weinstein slowly walked around a memorial honouring the nearly 400 ...